Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | JS006 |
Synonyms | |
Therapy Description |
JS006 is a monoclonal antibody that binds to TIGIT and inhibits ligand interaction, potentially leading to increased antitumor immune response (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
JS006 | JS-006|JS 006|TAB006|TAB 006|TAB-006 | TIGIT Antibody 19 | JS006 is a monoclonal antibody that binds to TIGIT and inhibits ligand interaction, potentially leading to increased antitumor immune response (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|